Fundraising Fox神曦生物
1 known investors
Find your way into 神曦生物
Sign up to see every warm intro you have to 神曦生物
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 神曦生物 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NeuExcell Therapeutics is a clinical-stage biopharmaceutical company developing neuro-regenerative therapies for neurodegenerative diseases and nerve injuries, with trials targeting glioma, Alzheimer's disease, and stroke. Its technology converts supportive glial cells into functional neurons for in-situ repair of damaged brain tissue.
Investors · 1
Frequently asked questions
- What does 神曦生物 do?
- NeuExcell Therapeutics is a clinical-stage biopharmaceutical company developing neuro-regenerative therapies for neurodegenerative diseases and nerve injuries, with trials targeting glioma, Alzheimer's disease, and stroke. Its technology converts supportive glial cells into functional neurons for in-situ repair of damaged brain tissue.
- Who are 神曦生物's investors?
- 神曦生物's investors include TriWise Capital.